Kanya Rajangam - Jul 18, 2022 Form 4 Insider Report for Senti Biosciences, Inc. (SNTI)

Role
Chief Medical & Devt. Officer
Signature
/s/ Mike Rhee, attorney-in-fact
Stock symbol
SNTI
Transactions as of
Jul 18, 2022
Transactions value $
$0
Form type
4
Date filed
7/20/2022, 06:00 PM
Previous filing
Jul 15, 2022
Next filing
Feb 2, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SNTI Stock Option (Right to Buy) Award $0 +328K $0.00 328K Jul 18, 2022 Common Stock 328K $1.80 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares underlying this option vest on July 5, 2023 and the remainder vest in 36 substantially equal monthly installments thereafter, subject to the reporting person's continued service through the applicable vesting date.